Cemiplimab for Metastatic Basal Cell Carcinoma: Exploring the Data With Karl Lewis, MD
Keira Smith
Expert Analysis
Cemiplimab, a programmed cell death protein 1 (PD-1) inhibitor, was approved in 2021 as the first and only systemic therapy to demonstrate clinical benefit among patients with advanced basal cell carcinoma (BCC) previously treated with hedgehog pathway inhibitor (HHI) therapy. At the American Association for Cancer Research (AACR) Annual Meeting in...
From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community With Reverend Sean Parker Dennison
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community At the recent 47th Annual Oncology Nursing Society (ONS) Congress, Reverend Sean Parker Dennison, alongside three other professionals, held a panel that explored the topic of improving quality of care for LGBTQIA+ individ...
Treating Advanced and Radioactive Iodine-Refractory Thyroid Cancer With Jochen Lorch, MD
Eden Maack
Expert Analysis
Dr. Jochen Lorch, MD, MSc, is a Professor of Medicine and Medical Oncologist specializing in head, neck, and thyroid cancers at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. Dr. Lorch discusses the challenges of selecting treatment for advanced thyroid cancers, the importance of molecular testing for selection of kinase inhibitors in thyroid cancers, and future directions of research in thyroid cancer treatment selection and sequencing.  
Addressing Racial Disparities in Multiple Myeloma Treatment Outcomes With Rahul Banerjee, MD, and Samer Al Hadidi, MD, MS, FACP
Keira Smith
Expert Analysis
Research has shown that Black American patients with multiple myeloma experience significant disparities in treatment patterns and outcomes compared with White patients. In this interview, Oncology Data Advisor editorial board member Dr. Rahul Banerjee speaks with Dr. Samer Al Hadidi, Assistant Professor at the University of Arkansas Medical School and a leading researcher in the field of multiple myeloma treatment disparities. Dr. Al Hadidi explains the differences in disease biology and treatment outcomes experienced by Black patients and shares solutions for closing this gap and ensuring equal access to care for all patients with multiple myeloma.  
Distinguishing BCMA-Directed Therapeutic Strategies for Multiple Myeloma With Charise Gleason, MSN, NP-BC, AOCNP®
Keira Smith
Expert Analysis
At the 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Charise Gleason, Advanced Practice Provider Chief at Emory University Winship Cancer Institute, spoke about the current role of B-cell maturation antigen (BCMA)–directed therapeutic approaches in the multiple myeloma treatment landscape. In this interview with Oncolo...
Designing Innovative Education for Nursing Development With Leah Scaramuzzo and Alisha Ellis
Lyn Brook
Expert Analysis
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Leah Scaramuzzo, MSN, RN, MEDSURG-BC, AOCN®, Nursing Director for Oncology Clinical Development at Logan Health, and Alisha Ellis, MSN, RN, OCN®, CHPN, BMTCN®, Staff Nurse and Educator in the Bone Marrow Transplant and Hematology Unit at Franciscan Health, presented an engaging session on how to Capture Your Audience With Innovative Education. Afterwards, they spoke with Oncology Data Advisor to continue their conversation and provide further expertise on how implement creative educational resources into practice, for both patients and providers.  
Supporting Patients Who Are Experiencing Financial Toxicity With Grace Smith, MD, PhD, MPH
Lyn Brook
Expert Analysis
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Grace Smith, Associate Professor at MD Anderson Cancer Center, gave a presentation about the financial toxicity associated with cancer care, particularly in light of the COVID-19 pandemic. In this interview with Oncology Data Advisor, Dr. Smith shares advice for nurses about how they can help prepare, identify, evaluate, and support patients who may experience financial toxicity.  
Raising Awareness About Medical Aid in Dying With Janet Rowe and Lisa Vigil Schattinger
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Raising Awareness About Medical Aid in Dying With Janet Rowe and Lisa Vigil Schattinger At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Janet Rowe, RN, and Lisa Vigil Schattinger, MSN, RN, gave a presentation about medical aid in dying and the nurse's role in supporting their terminally ill patients' rights to autonomous decision-making. In this interview with Oncology Data Advisor, Ms. Rowe and Ms. Vigil Schattinger discuss their own experiences with medical aid in dying, explain their work to spread awareness and provide education to the community, and share additional advice for nurses on how to engage patients and families in meaningful conversations about this important issue.
Reigniting the Passion as an Oncology Nurse With Nicola Stewart, MHL, BSN, RN-BC, OCN®
Lyn Brook
Expert Analysis
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Nicola Stewart, Oncology Nurse Navigator at Methodist Healthcare/Sarah Cannon Cancer Institute, gave a presentation about boosting nursing morale by investing in the individual person and building the team. In this interview with Oncology Data Advisor, she shares additional advice for reigniting the passion as an oncology nurse, including the importance of remembering your "why."  
From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community With Reverend Sean Parker Dennison
Lyn Brook
Expert Analysis
At the recent 47th Annual Oncology Nursing Society (ONS) Congress, Reverend Sean Parker Dennison, alongside three other professionals, held a panel that explored the topic of improving quality of care for LGBTQIA+ individuals with cancer. In this follow-up interview with Oncology Data Advisor, Reverend Sean expands on their thoughts and provides the valuable perspective of their personal experience as a transgender patient in the cancer care community.  
Survey of Oncology Nurses Reveals Need for Knowledge Regarding Genetic Evaluation and LGBTQIA+ Cancer Care
Lyn Brook
Expert Analysis
In May of 2022, i3 Health conducted a survey of 230 oncology nurses at the Oncology Nursing Society (ONS) 47th Annual Congress in Anaheim, California, to assess nurses' familiarity and desire to understand genetic evaluation and counseling and LGBTQIA+ cancer care. Genetic evaluation and counseling are ways for patients to better understand their g...
Discussing Successful Onboarding for APRNs With Maritza Alencar, DNP, MBA, APRN-BC, BMTCN®
Lyn Brook
Expert Analysis
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Maritza Alencar of the University of Miami Sylvester Comprehensive Cancer Center gave a presentation about the role of an effective onboarding program for advanced practice registered nurses (APRNs). In this interview, Dr. Alencar provides additional insights into this importance of this training in order to minimize burnout and shares resources to aid in the development of a well-structured onboarding program.
Providing Optimal Care for Cancer Patients in Rural Alaska With Joscelyn VanDuren, MSN, FNP-C
Lyn Brook
Expert Analysis
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Joscelyn VanDuren, Family Nurse Practitioner at Advanced Oncology Associates in Alaska, gave a presentation about the challenges faced by patients receiving cancer treatment in rural Alaska and her experiences in treating them. Afterwards, she spoke with Oncology Data Advisor to share additional strategies for nurses and nurse practitioners for providing optimal care for their patients residing in rural areas.  
Exploring Cognitive Function Research for Cancer Survivorship With Diane Von Ah, PhD, RN, FAAN
Lyn Brook
Expert Analysis
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Diane Von Ah, Distinguished Professor of Cancer Research at The Ohio State University College of Nursing, gave a presentation about the current state of research regarding cognitive impairment and functional limitation among cancer patients and survivors. In this interview, Dr. Von Ah further expands on her research in this field and explains the role of nurses in improving patients' quality of life both during and after treatment.  
Considering CAR T-Cell Therapy Survivorship Care With Sherry Adkins, ANP-C
Keira Smith
Expert Analysis
At the recent 47th Oncology Nursing Society (ONS) Congress in Anaheim, California, Sherry Adkins, MSN, ANP-C, Advanced Practice Provider Supervisor at MD Anderson Cancer Center, gave a presentation entitled CAR T-Cell Therapy: Care and Considerations Beyond Day 28. She highlighted the fact that although the most common acute toxicities associated w...
Starting the Conversation About the Cost of Cancer Care With Mateo Banegas, PhD, MPH
Keira Smith
Expert Analysis
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Mateo Banegas of the University of California, San Diego (UCSD) gave a presentation about the financial toxicity of cancer care, particularly during the COVID-19 pandemic. In this interview with Oncology Data Advisor, Dr. Banegas shares additional advice for members of the cancer care team on how to engage in conversations about financial costs and well-being with their patients.  
Improving Quality of Care for the LGBTQIA+ Cancer Community With Don S. Dizon, MD
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Improving Quality of Care for the LGBTQIA+ Cancer Community With Don Dizon In this interview with Oncology Data Advisor, Dr. Don S. Dizon continues the conversation he had at the recent 47th Annual Oncology Nursing Society (ONS) Congress, where he and three other professionals held a panel to spearhead the topic of improving quality of care for LGBTQIA+ individuals with cancer.
Utilizing Technology and Social Media in Oncology Research With Dr. Lisa Carter-Harris and Dr. Kelly Brassil
Keira Smith
Expert Analysis
At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Lisa Carter-Harris of Memorial Sloan Kettering Cancer Center and Dr. Kelly Brassil of MD Anderson Cancer Center each gave a presentation about ethical considerations in oncology research in light of the latest technological platforms and interventions. Aft...
Raising Awareness About Medical Aid in Dying With Janet Rowe and Lisa Vigil Schattinger
Keira Smith
Expert Analysis
At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Janet Rowe, RN, and Lisa Vigil Schattinger, MSN, RN, gave a presentation about medical aid in dying and the nurse's role in supporting their terminally ill patients' rights to autonomous decision-making. In this interview with Oncology Data Advisor, Ms. Rowe and Ms. Vigil Schattinger discuss their own experiences with medical aid in dying, explain their work to spread awareness and provide education to the community, and share additional advice for nurses on how to engage patients and families in meaningful conversations about this important issue.  
Improving Safety and Efficiency of Oral Chemotherapy Administration With Cynthia Huff, DNP, RN
Keira Smith
Expert Analysis
At the recent 47th Oncology Nursing Society (ONS) Congress in Anaheim, California, Cynthia Huff, DNP, RN, MSN, OCN®, CRNI, CNL®, Manager of the Ambulatory Infusion Center at Long Beach Medical Center, presented two posters about the importance of safe oral chemotherapy administration and the need to ensure proper lab monitoring and follow-up for pa...

Copyright © 2022 Oncology Data Advisor. All rights reserved.